- Design
- prospective cohort with quantitative CT phenotyping and multivariate logistic regression, stratified analysis
- Population
- 215 patients with COPD split by mucus plug score (cutoff 4) and emphysema (%LAA-950 cutoff 5%) into four subgroups of 46–62
- Primary outcome
- acute exacerbation of COPD
- Effect
- adjusted odds ratios vs low mucus/low emphysema: 2.885 (95% CI 1.060–8.166), 3.134 (1.212–8.540), 3.297 (1.096–10.298); mucus plugs significant only in the low-emphysema subgroup (3.318, 1.114–10.731)
Quantitative CT can now score both mucus plugging and emphysema, and the question is whether either adds to the clinical assessment. This prospective cohort of 215 patients with COPD split them on a mucus plug score of 4 and emphysema at 5% low attenuation area below −950 Hounsfield units, giving four subgroups, then looked at acute exacerbations.
Against the low-mucus, low-emphysema reference, adjusted odds of exacerbation were 2.885 (95% CI 1.060–8.166) for high emphysema alone, 3.134 (1.212–8.540) for high mucus alone, and 3.297 (1.096–10.298) for both. Each one-point rise in mucus plug score carried an odds ratio of 1.111 (1.005–1.232).
The stratified result is the interesting one and it cuts against the headline. Mucus plugging was significantly associated with exacerbation only in the low-emphysema subgroup (odds ratio 3.318, 1.114–10.731). Where emphysema was already extensive, additional mucus plugging added nothing detectable — the risk was already high. So this is not a simple additive model, and the combined group's odds ratio of 3.297 is barely above either single feature alone. The clinically useful reading is narrower than the abstract's: in a patient with limited emphysema, mucus plugging identifies risk that the emphysema score does not.
- Look at the CT you already have for mucus plugging in patients whose emphysema is mild but who exacerbate.
- This is a risk marker, not a treatment target — no trial has shown that treating mucus plugs reduces exacerbations.
- Consider bronchiectasis, eosinophilic airway disease and asthma-COPD overlap in a patient with heavy plugging and little emphysema; the phenotype may not be pure COPD.
- Quantitative CT scoring is not routinely available outside research and larger Indian centres, but visible plugging on a standard scan is a reasonable proxy.
- Exacerbation history remains the strongest predictor of future exacerbation and was presumably adjusted for; nothing here displaces it.
Why it matters
It suggests the imaging you already have distinguishes two routes to exacerbation that are currently managed identically.
Don't overread it
This was an observational cohort with wide confidence intervals and small subgroups — it identifies an association, not a phenotype ready for targeted treatment.
The statistics, in plain English
Note how wide the confidence intervals are: 1.060 to 8.166, 1.096 to 10.298. Each just clears 1.0, which with 215 patients split four ways means these are fragile findings resting on small subgroup counts of 46 to 62. The three odds ratios — 2.885, 3.134, 3.297 — are close enough to each other that the ordering between them means nothing, and the apparent dose-response across subgroups is not a real gradient. A per-point odds ratio of 1.111 with a lower bound of 1.005 is effectively at the edge of significance.
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.
Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for pulmonology, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free